DAVENPORT & Co LLC quarter change: USA Everything Else, Unchanged
In partnership units, exchange-traded notes and anything else (listed in the US), from the quarter ended 2026-03-31 to 2026-06-30, DAVENPORT & Co LLC opened 0 positions, added to 0, reduced 0, sold out of 0 and left 1 unchanged. The largest increase in value was BIOMARIN PHARMACEUTICAL INC (+$10,774); the largest decrease was BIOMARIN PHARMACEUTICAL INC (+$10,774).
- BIOMARIN PHARMACEUTICAL INC: Country of operation United States; Class NOTE 1.250% 5/1; Shares 2026-03-31 10,000; Shares 2026-06-30 10,000.
Two Form 13F-HR filings compared (SEC CIK 887777): 2026-03-31 (filed 2026-04-15) and 2026-06-30 (filed 2026-07-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| NVIDIA CORP | United States | $18.374B | 7 |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | Sweden | $18.343B | 538 |
| Tredje AP-fonden | Sweden | $18.284B | 555 |
| AE Wealth Management LLC | United States | $18.493B | 32,377 |
| Sanctuary Advisors, LLC | United States | $18.500B | 2,534 |
| Capital Wealth Planning, LLC | United States | $18.134B | 189 |
| BROWN BROTHERS HARRIMAN & CO | United States | $18.648B | 1,800 |
| HUNTINGTON NATIONAL BANK | United States | $18.124B | 6,012 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | United States | $18.083B | 457 |
| Envestnet Portfolio Solutions, Inc. | United States | $18.069B | 1,286 |